Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for CIP System Operation – V 2.0

Posted on By

Elixir Department: SOP for CIP System Operation – V 2.0

Standard Operating Procedure for CIP System Operation in Elixir Manufacturing

Department Elixir Department
SOP No. SOP/ELX/133/2025
Supersedes SOP/ELX/133/2022
Page No. Page 1 of 10
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To define the standard procedure for the operation of the Clean-in-Place (CIP) system used in the Elixir Department to ensure effective and validated cleaning of internal product contact surfaces of tanks, pipelines, and associated equipment.

2. Scope

This SOP is applicable to all automated and semi-automated CIP systems used for cleaning manufacturing and holding tanks, transfer lines, and filling equipment used in elixir production.

3. Responsibilities

  • Production Operator:
    • Perform CIP operations as per approved cycle parameters.
    • Record process parameters and verify cleaning completion.
  • Engineering Department:
    • Maintain CIP system performance and perform periodic validation.
  • QA Officer:
    • Review CIP logs and verify cleaning effectiveness through swab/rinse testing.
See also  Elixir Department: SOP for Maintaining Volume Adjustments - V 2.0

4. Accountability

The Production Head is accountable for ensuring proper cleaning is performed using the CIP system. The Engineering Head is accountable for the system’s calibration and maintenance.

5. Procedure

5.1 Pre-CIP Checks

  1. Verify that the system is labeled “READY FOR CLEANING.”
  2. Ensure the supply of utilities such as water, compressed air, and cleaning agents (alkaline/acidic).
  3. Confirm connection of CIP return and delivery lines to the appropriate tanks and pipelines.
  4. Check that drain valves are properly closed and flow paths are correctly aligned.

5.2 CIP Cycle Parameters

  1. Typical CIP cycle includes:
    • Pre-rinse with purified water: 5–10 minutes
    • Detergent wash (e.g., 1–2% NaOH solution): 15–20 minutes at 60–80°C
    • Intermediate rinse with purified water: 5–10 minutes
    • Acid wash (e.g., 0.5% nitric acid): 10 minutes (if applicable)
    • Final rinse with purified water until rinse water pH is neutral
  2. Adjust duration and temperature as per equipment type and validation report.
See also  Elixir Department: SOP for Use of Jacketed Heating Tanks - V 2.0

5.3 CIP Operation

  1. Start the CIP control panel and select the appropriate cleaning recipe.
  2. Monitor and log parameters such as temperature, flow rate, pressure, and conductivity.
  3. Ensure no leakage or overflow occurs during cleaning.
  4. On completion of the cycle, verify that rinse water is clear and pH is within 6.5–7.5.

5.4 Post-CIP Activities

  1. Drain any remaining cleaning solution from the tank and pipelines.
  2. Disconnect the CIP lines and store them as per standard storage SOP.
  3. Inspect the cleaned equipment visually for absence of residues.
  4. Affix the “CLEANED” status label after successful QA clearance.
  5. Record all observations in the CIP Log (Annexure-1).

5.5 Safety and Precautions

  1. Wear appropriate PPE including apron, gloves, face shield, and safety shoes.
  2. Handle cleaning agents with caution—refer to respective SDS for safe handling.
  3. Ensure drains are not blocked to avoid flooding.
  4. Never open tanks or valves under pressure during the cycle.

See also  Elixir Department: SOP for Backup Power Supply Systems for Critical Equipment - V 2.0

6. Abbreviations

  • SOP: Standard Operating Procedure
  • CIP: Clean-in-Place
  • QA: Quality Assurance
  • SDS: Safety Data Sheet

7. Documents

  1. CIP Log (Annexure-1)
  2. CIP Cycle Printout/Report (if PLC-based)
  3. Cleaning Validation Protocol/Report

8. References

  • 21 CFR Part 211.67 – Equipment Cleaning and Maintenance
  • WHO TRS 986 – GMP Cleaning Practices
  • ICH Q9 – Quality Risk Management

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: CIP Log

Date Equipment ID Cycle Type Detergent Used Final Rinse pH Operator QA Verified
11/04/2025 MIX-303 Standard 1.5% NaOH 7.1 Rajesh Kumar Sunita Reddy

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial SOP Release New SOP QA Head
11/04/2025 2.0 Added detailed parameters and buffer instructions Process Optimization QA Head
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: Gel Manufacturing: SOP for Validation of Mixing and Homogenization Processes – V 2.0
Next Post: Regulatory Impact of Missing SOPs for Deviation Management

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version